Symposium:
89. MERS: Four Years On
Thursday, October 27, 2016: 2:00 PM-3:30 PM
Room: 391-392

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the current status of the epidemiology of MERS-CoV
  • recognize common and unique clinical features of MERS-CoV infection
  • describe the classification of the various vaccine and therapeutic candidates for MES-CoV under investigation

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Microbiologists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Global ID, Epidemiology and Infection Control

Moderators:  Susan Gerber, MD, Centers for Disease Control and Prevention and Hana El Sahli, MD, Baylor College of Medicine

Presentations:
2:00 PM
823
Current Global Epidemiology of MERS-CoV
John Watson, MD, MPH

2:30 PM
824
MERS-CoV in an Emergency Room: Epidemiology of Outbreak and Control Measures
Yae-Jean Kim, MD, PhD
3:00 PM
825
Medical Countermeasures Development for MERS-CoV
David Spiro, PhD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-237-L01-P

Disclosures:

S. Gerber, None

H. El Sahli, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.